9:00 JST, May 3, 2023
TOKYO (Jiji Press) — Four major Japanese department store operators reported year-on-year sales growth for April, led by strong demand for summer clothing items amid rising temperatures.
Sales of duty-free goods, a measure of consumption by foreign visitors to Japan, were also brisk, with Daimaru Matsuzakaya Department Stores Co., a unit of J. Front Retailing Co., marking a 4.9-fold increase.
Daimaru Matsuzakaya saw its overall sales grow 19.1% on a same-store basis.
Sales rose 17.2% at Isetan Mitsukoshi Holdings Ltd., 11.8% at Takashimaya Co. and 8.6% at Sogo & Seibu Co., a unit of Seven & i Holdings Co., according to preliminary reports released by the companies on Monday.
Isetan Mitsukoshi and Takashimaya saw their respective sales exceed the levels in April 2019, before the COVID-19 pandemic.
By product, T-shirts, sandals and sunglasses sold well. Suitcases also saw brisk demand ahead of Japan’s Golden Week holiday period between late April and early May.
Duty-free sales jumped 4.2-fold at Isetan Mitsukoshi, 3.1-fold at Sogo & Seibu and 2.8-fold at Takashimaya. Luxury brand handbags enjoyed strong sales.
Top Articles in Business
-
Nippon Life Insurance’s U.S. Arm Sues OpenAI Over Legal Assistance Provided by ChatGPT
-
Japan, U.S. Name 3 Inaugural Investment Projects; Reached Agreement After Considerable Difficulty
-
Japan’s Major Real Estate Firms Expanding Overseas Businesses to Secure Future Growth, Focusing on Europe, U.S., Asia
-
JR Tokai Breaks Ground on Yamanashi Maglev Station; Will Be Part of Linear Chuo Shinkansen Line from Tokyo to Nagoya
-
Transport Companies See Opportunity in Narita Expansion; Airlines, Railways Prepare to Meet Expected Growth in Demand
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

